Carolini Kaid

Carolin Kaid has held a number of positions in the scientific field. Carolini began their career in 2008 as a Graduate Student at Universidad de Santiago de Compostela-Aula de Productos Lácteos. From 2013 to 2019, they were a PhD Student and Master at Universidade de São Paulo. In 2019, they became a PhD at Centro de Estudos sobre o Genoma Humano (IB/USP). Currently, they serve as the Chief Scientific Officer at Vyro Biotherapeutics.

Carolini Kaid has a comprehensive educational history. Carolini earned a Ciências Biológicas degree from USP - Universidade de São Paulo in 2007-2012, followed by a Master's degree in Oncologia e Biologia do Câncer in 2013-2014. Carolini then completed a Doutorado in Cancer Genetics from USP - Universidade de São Paulo in 2015-2018, followed by a PhD in Cancer genetics in 2015-2019. Carolini is currently pursuing a Pós-doutorado in Oncologia e Biologia do Câncer at USP - Universidade de São Paulo from 2019-2022.